Jefferies downgraded CSL Limited to 'hold' from 'buy', slashing its price target to A$108 from A$195—a 45% reduction.
The brokerage cited compounding pressures in CSL's Vifor and Behring divisions, leaving FY27 net profit estimates 10% below consensus.
CSL shares traded at A$99.26, against a 52-week range of A$93.64 to A$275.79, giving a market cap of A$48.3 billion.
Jefferies also cut FY27 revenue forecast to US$15.46 billion from US$15.73 billion.
